Research programme: heat shock protein 90 inhibitors - Quorex
Alternative Names: Heat shock protein 90 inhibitors - Quorex; HSP90 inhibitors - QuorexLatest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Quorex Pharmaceuticals
- Class Small molecules
- Mechanism of Action Heat-shock protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA
- 12 Jul 2004 Preclinical trials in Cancer in USA (unspecified route)